Last Price$3.18NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/27/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$3.13 (1)
Ask (Size)$3.25 (80)
Day Low / HighN/A - N/A
Volume1.8 M

Omeros Closes $1 Billion Sale of Omidria Eye Medication

10:08AM ET 12/23/2021 MT Newswires
Omeros Corp. (OMER) said Thursday it has closed the sale of Omidria eye medication to Rayner Surgical in a deal valued in excess of $1 billion.

The biopharmaceutical company received $126 million in upfront cash and may also receive up to $200 million in milestone payments and royalties on net sales. It is also eligible to collect its account receivables as of the closing date, according to a statement.

Omidria is used during cataract surgery or intraocular lens replacement to help reduce postoperative ocular pain.

Price: 7.59, Change: +0.06, Percent Change: +0.80